# Columbia Sportswear Co: financial statements, quarterly

COLM · Nasdaq · CIK 1050797 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/colm.md) · [Financials](/companies/colm/financials.md) · [Filings](/companies/colm/filings.md) · [Insiders](/companies/colm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/colm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [986](/filings/0001050797-24-000146.md) | [1,060 d](/filings/0001050797-26-000028.md) | [770](/filings/0001050797-25-000088.md) | [570](/filings/0001050797-25-000131.md) | [932](/filings/0001050797-25-000160.md) | [1,097 d](/filings/0001050797-26-000028.md) | [778](/filings/0001050797-26-000089.md) | [605](/filings/0001050797-26-000136.md) | [943](/filings/0001050797-25-000160.md) | [1,070 d](/filings/0001050797-26-000028.md) | [779](/filings/0001050797-26-000089.md) | [614](/filings/0001050797-26-000136.md) |
| Cost of revenue | $m | [505](/filings/0001050797-24-000146.md) | [524 d](/filings/0001050797-26-000028.md) | [380](/filings/0001050797-25-000088.md) | [297](/filings/0001050797-25-000131.md) | [464](/filings/0001050797-25-000160.md) | [536 d](/filings/0001050797-26-000028.md) | [382](/filings/0001050797-26-000089.md) | [308](/filings/0001050797-26-000136.md) | [472](/filings/0001050797-25-000160.md) | [518 d](/filings/0001050797-26-000028.md) | [384](/filings/0001050797-26-000089.md) | [256](/filings/0001050797-26-000136.md) |
| Gross profit | $m | [480](/filings/0001050797-24-000146.md) | [536 d](/filings/0001050797-26-000028.md) | [390](/filings/0001050797-25-000088.md) | [273](/filings/0001050797-25-000131.md) | [468](/filings/0001050797-25-000160.md) | [561 d](/filings/0001050797-26-000028.md) | [396](/filings/0001050797-26-000089.md) | [297](/filings/0001050797-26-000136.md) | [472](/filings/0001050797-25-000160.md) | [552 d](/filings/0001050797-26-000028.md) | [395](/filings/0001050797-26-000089.md) | [358](/filings/0001050797-26-000136.md) |
| Selling, general and administrative | $m | [352](/filings/0001050797-24-000146.md) | [405 d](/filings/0001050797-26-000028.md) | [349](/filings/0001050797-25-000088.md) | [303](/filings/0001050797-25-000131.md) | [361](/filings/0001050797-25-000160.md) | [431 d](/filings/0001050797-26-000028.md) | [354](/filings/0001050797-26-000089.md) | [326](/filings/0001050797-26-000136.md) | [381](/filings/0001050797-25-000160.md) | [442 d](/filings/0001050797-26-000028.md) | [357](/filings/0001050797-26-000089.md) | [332](/filings/0001050797-26-000136.md) |
| Operating income | $m | [135](/filings/0001050797-24-000146.md) | [113 d](/filings/0001050797-26-000028.md) | [44.7](/filings/0001050797-25-000088.md) | [(23.8)](/filings/0001050797-25-000131.md) | [113](/filings/0001050797-25-000160.md) | [137 d](/filings/0001050797-26-000028.md) | [46.5](/filings/0001050797-26-000089.md) | [(23.6)](/filings/0001050797-26-000136.md) | [67.4](/filings/0001050797-25-000160.md) | [117 d](/filings/0001050797-26-000028.md) | [42.0](/filings/0001050797-26-000089.md) | [30.9](/filings/0001050797-26-000136.md) |
| Income tax | $m | [32.6](/filings/0001050797-24-000146.md) | [26.6 d](/filings/0001050797-26-000028.md) | [11.8](/filings/0001050797-25-000088.md) | [(3.2)](/filings/0001050797-25-000131.md) | [29.0](/filings/0001050797-25-000160.md) | [37.3 d](/filings/0001050797-26-000028.md) | [12.6](/filings/0001050797-26-000089.md) | [(6.4)](/filings/0001050797-26-000136.md) | [19.0](/filings/0001050797-25-000160.md) | [27.2 d](/filings/0001050797-26-000028.md) | [13.0](/filings/0001050797-26-000089.md) | [9.7](/filings/0001050797-26-000136.md) |
| Net income | $m | [104](/filings/0001050797-24-000146.md) | [93.3 d](/filings/0001050797-26-000028.md) | [42.3](/filings/0001050797-25-000088.md) | [(11.7)](/filings/0001050797-25-000131.md) | [90.2](/filings/0001050797-25-000160.md) | [103 d](/filings/0001050797-26-000028.md) | [42.2](/filings/0001050797-26-000089.md) | [(10.2)](/filings/0001050797-26-000136.md) | [52.0](/filings/0001050797-25-000160.md) | [93.2 d](/filings/0001050797-26-000028.md) | [34.3](/filings/0001050797-26-000089.md) | [26.6](/filings/0001050797-26-000136.md) |
| Diluted EPS | $ per share | [1.70](/filings/0001050797-24-000146.md) | not reported | [0.71](/filings/0001050797-25-000088.md) | [(0.20)](/filings/0001050797-25-000131.md) | [1.56](/filings/0001050797-25-000160.md) | not reported | [0.75](/filings/0001050797-26-000089.md) | [(0.19)](/filings/0001050797-26-000136.md) | [0.95](/filings/0001050797-25-000160.md) | not reported | [0.65](/filings/0001050797-26-000089.md) | [0.52](/filings/0001050797-26-000136.md) |
| Basic EPS | $ per share | [1.70](/filings/0001050797-24-000146.md) | not reported | [0.71](/filings/0001050797-25-000088.md) | [(0.20)](/filings/0001050797-25-000131.md) | [1.56](/filings/0001050797-25-000160.md) | not reported | [0.76](/filings/0001050797-26-000089.md) | [(0.19)](/filings/0001050797-26-000136.md) | [0.95](/filings/0001050797-25-000160.md) | not reported | [0.65](/filings/0001050797-26-000089.md) | [0.52](/filings/0001050797-26-000136.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [213](/filings/0001050797-24-000146.md) | [350](/filings/0001050797-26-000028.md) | [418](/filings/0001050797-25-000088.md) | [342](/filings/0001050797-25-000131.md) | [307](/filings/0001050797-25-000160.md) | [532](/filings/0001050797-26-000136.md) | [323](/filings/0001050797-25-000088.md) | [428](/filings/0001050797-25-000131.md) | [229](/filings/0001050797-25-000160.md) | [442](/filings/0001050797-26-000136.md) | [319](/filings/0001050797-26-000089.md) | [532](/filings/0001050797-26-000136.md) |
| Current assets | $m | [1,883](/filings/0001050797-24-000146.md) | [2,015](/filings/0001050797-25-000023.md) | [1,846](/filings/0001050797-25-000088.md) | [1,848](/filings/0001050797-25-000131.md) | [1,826](/filings/0001050797-25-000160.md) | [2,009](/filings/0001050797-26-000028.md) | [1,741](/filings/0001050797-25-000088.md) | [1,894](/filings/0001050797-25-000131.md) | [1,746](/filings/0001050797-25-000160.md) | [1,972](/filings/0001050797-26-000136.md) | [1,618](/filings/0001050797-26-000089.md) | [1,866](/filings/0001050797-26-000136.md) |
| Total assets | $m | [2,799](/filings/0001050797-24-000146.md) | [2,939](/filings/0001050797-25-000023.md) | [2,762](/filings/0001050797-25-000088.md) | [2,761](/filings/0001050797-25-000131.md) | [2,761](/filings/0001050797-25-000160.md) | [2,975](/filings/0001050797-26-000028.md) | [2,707](/filings/0001050797-25-000088.md) | [2,890](/filings/0001050797-25-000131.md) | [2,713](/filings/0001050797-25-000160.md) | [2,928](/filings/0001050797-26-000136.md) | [2,564](/filings/0001050797-26-000089.md) | [2,798](/filings/0001050797-26-000136.md) |
| Current liabilities | $m | [526](/filings/0001050797-24-000146.md) | [597](/filings/0001050797-25-000023.md) | [447](/filings/0001050797-25-000088.md) | [544](/filings/0001050797-25-000131.md) | [567](/filings/0001050797-25-000160.md) | [767](/filings/0001050797-26-000028.md) | [559](/filings/0001050797-25-000088.md) | [761](/filings/0001050797-25-000131.md) | [593](/filings/0001050797-25-000160.md) | [761](/filings/0001050797-26-000136.md) | [527](/filings/0001050797-26-000089.md) | [749](/filings/0001050797-26-000136.md) |
| Total liabilities | $m | [904](/filings/0001050797-24-000146.md) | [1,000](/filings/0001050797-25-000023.md) | [853](/filings/0001050797-25-000088.md) | [937](/filings/0001050797-25-000131.md) | [973](/filings/0001050797-25-000160.md) | [1,195](/filings/0001050797-26-000028.md) | [998](/filings/0001050797-25-000088.md) | [1,237](/filings/0001050797-25-000131.md) | [1,057](/filings/0001050797-25-000160.md) | [1,218](/filings/0001050797-26-000136.md) | [982](/filings/0001050797-26-000089.md) | [1,196](/filings/0001050797-26-000136.md) |
| Short-term borrowings | $m | [0.0](/filings/0001050797-23-000146.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,895](/filings/0001050797-24-000146.md) | [1,939](/filings/0001050797-26-000028.md) | [1,909](/filings/0001050797-25-000131.md) | [1,824](/filings/0001050797-25-000160.md) | [1,787](/filings/0001050797-25-000160.md) | [1,780](/filings/0001050797-26-000136.md) | [1,710](/filings/0001050797-26-000136.md) | [1,654](/filings/0001050797-26-000136.md) | [1,656](/filings/0001050797-25-000160.md) | [1,710](/filings/0001050797-26-000136.md) | [1,582](/filings/0001050797-26-000136.md) | [1,602](/filings/0001050797-26-000136.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.5 d](/filings/0001050797-24-000146.md) | [614 d](/filings/0001050797-26-000028.md) | [107](/filings/0001050797-25-000088.md) | [2.1 d](/filings/0001050797-25-000131.md) | [(186) d](/filings/0001050797-25-000160.md) | [568 d](/filings/0001050797-26-000028.md) | [(32.0)](/filings/0001050797-26-000089.md) | [(30.8) d](/filings/0001050797-26-000136.md) | [(271) d](/filings/0001050797-25-000160.md) | [616 d](/filings/0001050797-26-000028.md) | [(77.5)](/filings/0001050797-26-000089.md) | [115 d](/filings/0001050797-26-000136.md) |
| Capital expenditure | $m | [18.6 d](/filings/0001050797-24-000146.md) | [13.3 d](/filings/0001050797-26-000028.md) | [14.8](/filings/0001050797-25-000088.md) | [13.0 d](/filings/0001050797-25-000131.md) | [13.9 d](/filings/0001050797-25-000160.md) | [18.1 d](/filings/0001050797-26-000028.md) | [15.6](/filings/0001050797-26-000089.md) | [14.5 d](/filings/0001050797-26-000136.md) | [16.6 d](/filings/0001050797-25-000160.md) | [19.5 d](/filings/0001050797-26-000028.md) | [12.4](/filings/0001050797-26-000089.md) | [13.4 d](/filings/0001050797-26-000136.md) |
| Dividends paid | $m | [18.3 d](/filings/0001050797-24-000146.md) | [18.1 d](/filings/0001050797-26-000028.md) | [17.9](/filings/0001050797-25-000088.md) | [17.7 d](/filings/0001050797-25-000131.md) | [17.2 d](/filings/0001050797-25-000160.md) | [16.9 d](/filings/0001050797-26-000028.md) | [16.6](/filings/0001050797-26-000089.md) | [16.4 d](/filings/0001050797-26-000136.md) | [16.4 d](/filings/0001050797-25-000160.md) | [16.1 d](/filings/0001050797-26-000028.md) | [15.6](/filings/0001050797-26-000089.md) | [15.4 d](/filings/0001050797-26-000136.md) |
| Share repurchases | $m | [66.3 d](/filings/0001050797-24-000146.md) | [39.4 d](/filings/0001050797-26-000028.md) | [50.2](/filings/0001050797-25-000088.md) | [52.5 d](/filings/0001050797-25-000131.md) | [128 d](/filings/0001050797-25-000160.md) | [86.9 d](/filings/0001050797-26-000028.md) | [101](/filings/0001050797-26-000089.md) | [30.3 d](/filings/0001050797-26-000136.md) | [40.0 d](/filings/0001050797-25-000160.md) | [29.4 d](/filings/0001050797-26-000028.md) | [150](/filings/0001050797-26-000089.md) | [0.0 d](/filings/0001050797-26-000136.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [62.2](/filings/0001050797-23-000146.md) | [62.4](/filings/0001050797-24-000071.md) | [61.8](/filings/0001050797-24-000129.md) | [60.9](/filings/0001050797-24-000146.md) | [60.0](/filings/0001050797-25-000088.md) | [59.1](/filings/0001050797-25-000131.md) | [57.9](/filings/0001050797-25-000160.md) | [56.0](/filings/0001050797-26-000089.md) | [54.8](/filings/0001050797-26-000136.md) | [54.6](/filings/0001050797-25-000160.md) | [52.7](/filings/0001050797-26-000089.md) | [51.3](/filings/0001050797-26-000136.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 51,193,194 at 2026-07-24, from the cover of the [10-Q filed 2026-08-06](/filings/0001050797-26-000136.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.